Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Safety & Tolerability Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated:  8/1/2013
Clinical Research Facility
mi
from
Oklahoma City, OK
Safety & Tolerability Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated: 8/1/2013
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Safety & Tolerability Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated:  8/1/2013
Clinical Research Facility
mi
from
Philadelphia, PA
Safety & Tolerability Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated: 8/1/2013
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Safety & Tolerability Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated:  8/1/2013
Clinical Research Facility
mi
from
Dallas, TX
Safety & Tolerability Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated: 8/1/2013
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Safety & Tolerability Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated:  8/1/2013
Clinical Research Facility
mi
from
San Antonio, TX
Safety & Tolerability Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated: 8/1/2013
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Safety & Tolerability Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated:  8/1/2013
Clinical Research Facility
mi
from
San Antonio, TX
Safety & Tolerability Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated: 8/1/2013
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Safety & Tolerability Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated:  8/1/2013
Clinical Research Facility
mi
from
Salt Lake City, UT
Safety & Tolerability Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated: 8/1/2013
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Safety & Tolerability Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated:  8/1/2013
Clinical Research Facility
mi
from
Charlottesville, VA
Safety & Tolerability Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated: 8/1/2013
Clinical Research Facility
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Safety & Tolerability Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated:  8/1/2013
Clinical Research Facility
mi
from
Norfolk, VA
Safety & Tolerability Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated: 8/1/2013
Clinical Research Facility
mi
from
Norfolk, VA
Click here to add this to my saved trials
Safety & Tolerability Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated:  8/1/2013
Clinical Research Facility
mi
from
Bothell, WA
Safety & Tolerability Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated: 8/1/2013
Clinical Research Facility
mi
from
Bothell, WA
Click here to add this to my saved trials
Safety & Tolerability Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated:  8/1/2013
Clinical Research Facility
mi
from
La Crosse, WI
Safety & Tolerability Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated: 8/1/2013
Clinical Research Facility
mi
from
La Crosse, WI
Click here to add this to my saved trials
Adherence Trial With MS LifeLines ® Services
A Prospective, Parallel Group, Phase IV Study of Three Levels of MS LifeLines ® Support Services Provided to Patients Prescribed Rebif ® for Newly Diagnosed or First-switch Relapsing Remitting Multiple Sclerosis (RRMS)
Status: Enrolling
Updated:  8/4/2013
Call EMD Serono Medical Information for information on recruiting sites
mi
from
Boston, MA
Adherence Trial With MS LifeLines ® Services
A Prospective, Parallel Group, Phase IV Study of Three Levels of MS LifeLines ® Support Services Provided to Patients Prescribed Rebif ® for Newly Diagnosed or First-switch Relapsing Remitting Multiple Sclerosis (RRMS)
Status: Enrolling
Updated: 8/4/2013
Call EMD Serono Medical Information for information on recruiting sites
mi
from
Boston, MA
Click here to add this to my saved trials
Comparison of Brain Network Activation (BNA™) Analysis, Clinical Symptoms and Neuro-cognitive Performance in Concussed Children and Young Adults
Comparison of Brain Network Activation Analysis (BNA™) Using Evoked Response Potentials, Clinical Symptoms and Neuro-cognitive Performance and Symptoms in Concussed Children, Young Adults and Matched Controls
Status: Enrolling
Updated:  8/13/2013
UPMC Sports Medicine Concussion Program
mi
from
Pittsburgh, PA
Comparison of Brain Network Activation (BNA™) Analysis, Clinical Symptoms and Neuro-cognitive Performance in Concussed Children and Young Adults
Comparison of Brain Network Activation Analysis (BNA™) Using Evoked Response Potentials, Clinical Symptoms and Neuro-cognitive Performance and Symptoms in Concussed Children, Young Adults and Matched Controls
Status: Enrolling
Updated: 8/13/2013
UPMC Sports Medicine Concussion Program
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
A Prospective Study of Brain Network Activation (BNA) Changes in High School Athletes Following Concussion
A Prospective Study of Brain Network Activation (BNA) Changes in High School Athletes Following Concussion
Status: Enrolling
Updated:  8/13/2013
UPMC Sports Medicine Concussion Program
mi
from
Pittsburgh, PA
A Prospective Study of Brain Network Activation (BNA) Changes in High School Athletes Following Concussion
A Prospective Study of Brain Network Activation (BNA) Changes in High School Athletes Following Concussion
Status: Enrolling
Updated: 8/13/2013
UPMC Sports Medicine Concussion Program
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Hepatic Encephalopathy: Lactulose or Polyethylene Glycol (H.E.L.P.)
Hepatic Encephalopathy: Lactulose or Polyethylene Glycol (H.E.L.P.)
Status: Enrolling
Updated:  8/13/2013
New York Methodist Hospital
mi
from
Brooklyn, NY
Hepatic Encephalopathy: Lactulose or Polyethylene Glycol (H.E.L.P.)
Hepatic Encephalopathy: Lactulose or Polyethylene Glycol (H.E.L.P.)
Status: Enrolling
Updated: 8/13/2013
New York Methodist Hospital
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Evaluation of the Effectiveness and Clinical Utility of Brain Network Activation (BNA™) Technology in the Management of Sport Related Concussion in Youth and Adolescents Athletes.
Evaluation of the Effectiveness and Clinical Utility of Brain Network Activation (BNA™) Technology in the Management of Sport Related Concussion in Youth and Adolescents Athletes.
Status: Enrolling
Updated:  8/14/2013
Athletico N. LaGrange Rd
mi
from
LaGrange park, IL
Evaluation of the Effectiveness and Clinical Utility of Brain Network Activation (BNA™) Technology in the Management of Sport Related Concussion in Youth and Adolescents Athletes.
Evaluation of the Effectiveness and Clinical Utility of Brain Network Activation (BNA™) Technology in the Management of Sport Related Concussion in Youth and Adolescents Athletes.
Status: Enrolling
Updated: 8/14/2013
Athletico N. LaGrange Rd
mi
from
LaGrange park, IL
Click here to add this to my saved trials
A Clinical Trial of Ambrisentan and Tadalafil in Pulmonary Arterial Hypertension Associated With Systemic Sclerosis
A Clinical Trial of Ambrisentan and Tadalafil in Pulmonary Arterial Hypertension Associated With Systemic Sclerosis
Status: Enrolling
Updated:  8/16/2013
Johns Hopkins University
mi
from
Baltimore, MD
A Clinical Trial of Ambrisentan and Tadalafil in Pulmonary Arterial Hypertension Associated With Systemic Sclerosis
A Clinical Trial of Ambrisentan and Tadalafil in Pulmonary Arterial Hypertension Associated With Systemic Sclerosis
Status: Enrolling
Updated: 8/16/2013
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Tadalafil in Becker Muscular Dystrophy
Functional Muscle Ischemia and PDE5A Inhibition in Becker Muscular Dystrophy
Status: Enrolling
Updated:  8/19/2013
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Tadalafil in Becker Muscular Dystrophy
Functional Muscle Ischemia and PDE5A Inhibition in Becker Muscular Dystrophy
Status: Enrolling
Updated: 8/19/2013
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Sleep Laboratory Study to Investigate the Safety and Efficacy of the Rotigotine Skin Patch in Subjects With Restless Legs Syndrome and End-Stage Renal Disease Requiring Hemodialysis
A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel-group, Polysomnography Study to Investigate Safety and Efficacy of the Rotigotine Transdermal Patch in Subjects With Restless Legs Syndrome and End-Stage Renal Disease Requiring Hemodialysis
Status: Enrolling
Updated:  8/19/2013
Clinical Research Facility
mi
from
Brandon, FL
A Sleep Laboratory Study to Investigate the Safety and Efficacy of the Rotigotine Skin Patch in Subjects With Restless Legs Syndrome and End-Stage Renal Disease Requiring Hemodialysis
A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel-group, Polysomnography Study to Investigate Safety and Efficacy of the Rotigotine Transdermal Patch in Subjects With Restless Legs Syndrome and End-Stage Renal Disease Requiring Hemodialysis
Status: Enrolling
Updated: 8/19/2013
Clinical Research Facility
mi
from
Brandon, FL
Click here to add this to my saved trials
A Sleep Laboratory Study to Investigate the Safety and Efficacy of the Rotigotine Skin Patch in Subjects With Restless Legs Syndrome and End-Stage Renal Disease Requiring Hemodialysis
A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel-group, Polysomnography Study to Investigate Safety and Efficacy of the Rotigotine Transdermal Patch in Subjects With Restless Legs Syndrome and End-Stage Renal Disease Requiring Hemodialysis
Status: Enrolling
Updated:  8/19/2013
Clinical Research Facility
mi
from
Chevy Chase, MD
A Sleep Laboratory Study to Investigate the Safety and Efficacy of the Rotigotine Skin Patch in Subjects With Restless Legs Syndrome and End-Stage Renal Disease Requiring Hemodialysis
A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel-group, Polysomnography Study to Investigate Safety and Efficacy of the Rotigotine Transdermal Patch in Subjects With Restless Legs Syndrome and End-Stage Renal Disease Requiring Hemodialysis
Status: Enrolling
Updated: 8/19/2013
Clinical Research Facility
mi
from
Chevy Chase, MD
Click here to add this to my saved trials
A Sleep Laboratory Study to Investigate the Safety and Efficacy of the Rotigotine Skin Patch in Subjects With Restless Legs Syndrome and End-Stage Renal Disease Requiring Hemodialysis
A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel-group, Polysomnography Study to Investigate Safety and Efficacy of the Rotigotine Transdermal Patch in Subjects With Restless Legs Syndrome and End-Stage Renal Disease Requiring Hemodialysis
Status: Enrolling
Updated:  8/19/2013
Clinical Research Facility
mi
from
Newton, MA
A Sleep Laboratory Study to Investigate the Safety and Efficacy of the Rotigotine Skin Patch in Subjects With Restless Legs Syndrome and End-Stage Renal Disease Requiring Hemodialysis
A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel-group, Polysomnography Study to Investigate Safety and Efficacy of the Rotigotine Transdermal Patch in Subjects With Restless Legs Syndrome and End-Stage Renal Disease Requiring Hemodialysis
Status: Enrolling
Updated: 8/19/2013
Clinical Research Facility
mi
from
Newton, MA
Click here to add this to my saved trials
A Sleep Laboratory Study to Investigate the Safety and Efficacy of the Rotigotine Skin Patch in Subjects With Restless Legs Syndrome and End-Stage Renal Disease Requiring Hemodialysis
A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel-group, Polysomnography Study to Investigate Safety and Efficacy of the Rotigotine Transdermal Patch in Subjects With Restless Legs Syndrome and End-Stage Renal Disease Requiring Hemodialysis
Status: Enrolling
Updated:  8/19/2013
Clinical Research Facility
mi
from
Mineola, NY
A Sleep Laboratory Study to Investigate the Safety and Efficacy of the Rotigotine Skin Patch in Subjects With Restless Legs Syndrome and End-Stage Renal Disease Requiring Hemodialysis
A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel-group, Polysomnography Study to Investigate Safety and Efficacy of the Rotigotine Transdermal Patch in Subjects With Restless Legs Syndrome and End-Stage Renal Disease Requiring Hemodialysis
Status: Enrolling
Updated: 8/19/2013
Clinical Research Facility
mi
from
Mineola, NY
Click here to add this to my saved trials
A Sleep Laboratory Study to Investigate the Safety and Efficacy of the Rotigotine Skin Patch in Subjects With Restless Legs Syndrome and End-Stage Renal Disease Requiring Hemodialysis
A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel-group, Polysomnography Study to Investigate Safety and Efficacy of the Rotigotine Transdermal Patch in Subjects With Restless Legs Syndrome and End-Stage Renal Disease Requiring Hemodialysis
Status: Enrolling
Updated:  8/19/2013
Clinical Research Facility
mi
from
West Seneca, NY
A Sleep Laboratory Study to Investigate the Safety and Efficacy of the Rotigotine Skin Patch in Subjects With Restless Legs Syndrome and End-Stage Renal Disease Requiring Hemodialysis
A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel-group, Polysomnography Study to Investigate Safety and Efficacy of the Rotigotine Transdermal Patch in Subjects With Restless Legs Syndrome and End-Stage Renal Disease Requiring Hemodialysis
Status: Enrolling
Updated: 8/19/2013
Clinical Research Facility
mi
from
West Seneca, NY
Click here to add this to my saved trials
A Sleep Laboratory Study to Investigate the Safety and Efficacy of the Rotigotine Skin Patch in Subjects With Restless Legs Syndrome and End-Stage Renal Disease Requiring Hemodialysis
A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel-group, Polysomnography Study to Investigate Safety and Efficacy of the Rotigotine Transdermal Patch in Subjects With Restless Legs Syndrome and End-Stage Renal Disease Requiring Hemodialysis
Status: Enrolling
Updated:  8/19/2013
Clinical Research Facility
mi
from
Dublin, OH
A Sleep Laboratory Study to Investigate the Safety and Efficacy of the Rotigotine Skin Patch in Subjects With Restless Legs Syndrome and End-Stage Renal Disease Requiring Hemodialysis
A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel-group, Polysomnography Study to Investigate Safety and Efficacy of the Rotigotine Transdermal Patch in Subjects With Restless Legs Syndrome and End-Stage Renal Disease Requiring Hemodialysis
Status: Enrolling
Updated: 8/19/2013
Clinical Research Facility
mi
from
Dublin, OH
Click here to add this to my saved trials
A Sleep Laboratory Study to Investigate the Safety and Efficacy of the Rotigotine Skin Patch in Subjects With Restless Legs Syndrome and End-Stage Renal Disease Requiring Hemodialysis
A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel-group, Polysomnography Study to Investigate Safety and Efficacy of the Rotigotine Transdermal Patch in Subjects With Restless Legs Syndrome and End-Stage Renal Disease Requiring Hemodialysis
Status: Enrolling
Updated:  8/19/2013
Clinical Research Facility
mi
from
West Chester, PA
A Sleep Laboratory Study to Investigate the Safety and Efficacy of the Rotigotine Skin Patch in Subjects With Restless Legs Syndrome and End-Stage Renal Disease Requiring Hemodialysis
A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel-group, Polysomnography Study to Investigate Safety and Efficacy of the Rotigotine Transdermal Patch in Subjects With Restless Legs Syndrome and End-Stage Renal Disease Requiring Hemodialysis
Status: Enrolling
Updated: 8/19/2013
Clinical Research Facility
mi
from
West Chester, PA
Click here to add this to my saved trials
A Sleep Laboratory Study to Investigate the Safety and Efficacy of the Rotigotine Skin Patch in Subjects With Restless Legs Syndrome and End-Stage Renal Disease Requiring Hemodialysis
A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel-group, Polysomnography Study to Investigate Safety and Efficacy of the Rotigotine Transdermal Patch in Subjects With Restless Legs Syndrome and End-Stage Renal Disease Requiring Hemodialysis
Status: Enrolling
Updated:  8/19/2013
Clinical Research Facility
mi
from
Austin, TX
A Sleep Laboratory Study to Investigate the Safety and Efficacy of the Rotigotine Skin Patch in Subjects With Restless Legs Syndrome and End-Stage Renal Disease Requiring Hemodialysis
A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel-group, Polysomnography Study to Investigate Safety and Efficacy of the Rotigotine Transdermal Patch in Subjects With Restless Legs Syndrome and End-Stage Renal Disease Requiring Hemodialysis
Status: Enrolling
Updated: 8/19/2013
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
Telephone Care Management to Address Sleep Problems in Young Children With Autism
Telephone Care Management to Address Sleep Problems in Young Children With Autism
Status: Enrolling
Updated:  8/19/2013
Nationwide Children's Hospital
mi
from
Columbus, OH
Telephone Care Management to Address Sleep Problems in Young Children With Autism
Telephone Care Management to Address Sleep Problems in Young Children With Autism
Status: Enrolling
Updated: 8/19/2013
Nationwide Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
A Single Site, Randomized, Double-blind, Placebo Controlled Trial of NIC5-15 in Subjects With Alzheimer's Disease
A Single Site, Randomized, Double-blind, Placebo Controlled Trial of NIC5-15 in Subjects With Alzheimer's Disease
Status: Enrolling
Updated:  8/20/2013
James J. Peters Veterans Affairs Medical Center
mi
from
Bronx, NY
A Single Site, Randomized, Double-blind, Placebo Controlled Trial of NIC5-15 in Subjects With Alzheimer's Disease
A Single Site, Randomized, Double-blind, Placebo Controlled Trial of NIC5-15 in Subjects With Alzheimer's Disease
Status: Enrolling
Updated: 8/20/2013
James J. Peters Veterans Affairs Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
Exercise For Sub-acute Stroke Patients in Jamaica
Jamaica and Maryland Mobility in Stroke
Status: Enrolling
Updated:  8/22/2013
University of Maryland
mi
from
Baltimore, MD
Exercise For Sub-acute Stroke Patients in Jamaica
Jamaica and Maryland Mobility in Stroke
Status: Enrolling
Updated: 8/22/2013
University of Maryland
mi
from
Baltimore, MD
Click here to add this to my saved trials
An Open-label Safety and Tolerability Study of ISIS SMNRx in Patients With Spinal Muscular Atrophy Who Previously Participated in ISIS 396443-CS1
An Open-label Study to Assess the Safety and Tolerability of a Single Intrathecal Dose of ISIS 396443 in Patients With Spinal Muscular Atrophy Who Previously Participated in ISIS 396443-CS1
Status: Enrolling
Updated:  8/22/2013
Boston Children's Hospital
mi
from
Boston, MA
An Open-label Safety and Tolerability Study of ISIS SMNRx in Patients With Spinal Muscular Atrophy Who Previously Participated in ISIS 396443-CS1
An Open-label Study to Assess the Safety and Tolerability of a Single Intrathecal Dose of ISIS 396443 in Patients With Spinal Muscular Atrophy Who Previously Participated in ISIS 396443-CS1
Status: Enrolling
Updated: 8/22/2013
Boston Children's Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
An Open-label Safety and Tolerability Study of ISIS SMNRx in Patients With Spinal Muscular Atrophy Who Previously Participated in ISIS 396443-CS1
An Open-label Study to Assess the Safety and Tolerability of a Single Intrathecal Dose of ISIS 396443 in Patients With Spinal Muscular Atrophy Who Previously Participated in ISIS 396443-CS1
Status: Enrolling
Updated:  8/22/2013
Columbia University Medical Center
mi
from
New York, NY
An Open-label Safety and Tolerability Study of ISIS SMNRx in Patients With Spinal Muscular Atrophy Who Previously Participated in ISIS 396443-CS1
An Open-label Study to Assess the Safety and Tolerability of a Single Intrathecal Dose of ISIS 396443 in Patients With Spinal Muscular Atrophy Who Previously Participated in ISIS 396443-CS1
Status: Enrolling
Updated: 8/22/2013
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
An Open-label Safety and Tolerability Study of ISIS SMNRx in Patients With Spinal Muscular Atrophy Who Previously Participated in ISIS 396443-CS1
An Open-label Study to Assess the Safety and Tolerability of a Single Intrathecal Dose of ISIS 396443 in Patients With Spinal Muscular Atrophy Who Previously Participated in ISIS 396443-CS1
Status: Enrolling
Updated:  8/22/2013
UT Southwestern Medical Center - Children's Medical Center Dallas
mi
from
Dallas, TX
An Open-label Safety and Tolerability Study of ISIS SMNRx in Patients With Spinal Muscular Atrophy Who Previously Participated in ISIS 396443-CS1
An Open-label Study to Assess the Safety and Tolerability of a Single Intrathecal Dose of ISIS 396443 in Patients With Spinal Muscular Atrophy Who Previously Participated in ISIS 396443-CS1
Status: Enrolling
Updated: 8/22/2013
UT Southwestern Medical Center - Children's Medical Center Dallas
mi
from
Dallas, TX
Click here to add this to my saved trials
An Open-label Safety and Tolerability Study of ISIS SMNRx in Patients With Spinal Muscular Atrophy Who Previously Participated in ISIS 396443-CS1
An Open-label Study to Assess the Safety and Tolerability of a Single Intrathecal Dose of ISIS 396443 in Patients With Spinal Muscular Atrophy Who Previously Participated in ISIS 396443-CS1
Status: Enrolling
Updated:  8/22/2013
University of Utah School of Medicine
mi
from
Salt Lake City, UT
An Open-label Safety and Tolerability Study of ISIS SMNRx in Patients With Spinal Muscular Atrophy Who Previously Participated in ISIS 396443-CS1
An Open-label Study to Assess the Safety and Tolerability of a Single Intrathecal Dose of ISIS 396443 in Patients With Spinal Muscular Atrophy Who Previously Participated in ISIS 396443-CS1
Status: Enrolling
Updated: 8/22/2013
University of Utah School of Medicine
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Darbe Administration in Newborns Undergoing Cooling for Encephalopathy
Darbe Administration in Newborns Undergoing Cooling for Encephalopathy
Status: Enrolling
Updated:  8/26/2013
University of New Mexico
mi
from
Albuquerque, NM
Darbe Administration in Newborns Undergoing Cooling for Encephalopathy
Darbe Administration in Newborns Undergoing Cooling for Encephalopathy
Status: Enrolling
Updated: 8/26/2013
University of New Mexico
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Darbe Administration in Newborns Undergoing Cooling for Encephalopathy
Darbe Administration in Newborns Undergoing Cooling for Encephalopathy
Status: Enrolling
Updated:  8/26/2013
Vanderbilt University School of Medicine
mi
from
Nashville, TN
Darbe Administration in Newborns Undergoing Cooling for Encephalopathy
Darbe Administration in Newborns Undergoing Cooling for Encephalopathy
Status: Enrolling
Updated: 8/26/2013
Vanderbilt University School of Medicine
mi
from
Nashville, TN
Click here to add this to my saved trials
Darbe Administration in Newborns Undergoing Cooling for Encephalopathy
Darbe Administration in Newborns Undergoing Cooling for Encephalopathy
Status: Enrolling
Updated:  8/26/2013
McKay Dee Hospital- Intermountain Healthcare
mi
from
Ogden, UT
Darbe Administration in Newborns Undergoing Cooling for Encephalopathy
Darbe Administration in Newborns Undergoing Cooling for Encephalopathy
Status: Enrolling
Updated: 8/26/2013
McKay Dee Hospital- Intermountain Healthcare
mi
from
Ogden, UT
Click here to add this to my saved trials
Darbe Administration in Newborns Undergoing Cooling for Encephalopathy
Darbe Administration in Newborns Undergoing Cooling for Encephalopathy
Status: Enrolling
Updated:  8/26/2013
Primary Children's Hospital
mi
from
Salt Lake City, UT
Darbe Administration in Newborns Undergoing Cooling for Encephalopathy
Darbe Administration in Newborns Undergoing Cooling for Encephalopathy
Status: Enrolling
Updated: 8/26/2013
Primary Children's Hospital
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Darbe Administration in Newborns Undergoing Cooling for Encephalopathy
Darbe Administration in Newborns Undergoing Cooling for Encephalopathy
Status: Enrolling
Updated:  8/26/2013
University of Utah
mi
from
Salt Lake City, UT
Darbe Administration in Newborns Undergoing Cooling for Encephalopathy
Darbe Administration in Newborns Undergoing Cooling for Encephalopathy
Status: Enrolling
Updated: 8/26/2013
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Darbe Administration in Newborns Undergoing Cooling for Encephalopathy
Darbe Administration in Newborns Undergoing Cooling for Encephalopathy
Status: Enrolling
Updated:  8/26/2013
Intermountain Medical Center
mi
from
Sandy, UT
Darbe Administration in Newborns Undergoing Cooling for Encephalopathy
Darbe Administration in Newborns Undergoing Cooling for Encephalopathy
Status: Enrolling
Updated: 8/26/2013
Intermountain Medical Center
mi
from
Sandy, UT
Click here to add this to my saved trials
Darbe Administration in Newborns Undergoing Cooling for Encephalopathy
Darbe Administration in Newborns Undergoing Cooling for Encephalopathy
Status: Enrolling
Updated:  8/26/2013
Univ of Washington
mi
from
Seattle, WA
Darbe Administration in Newborns Undergoing Cooling for Encephalopathy
Darbe Administration in Newborns Undergoing Cooling for Encephalopathy
Status: Enrolling
Updated: 8/26/2013
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Functional Vision in TBI
Functional Vision Consequences of Rehabilitation for TBI Vision Loss
Status: Enrolling
Updated:  8/29/2013
VA Palo Alto Health Care System
mi
from
Palo Alto, CA
Functional Vision in TBI
Functional Vision Consequences of Rehabilitation for TBI Vision Loss
Status: Enrolling
Updated: 8/29/2013
VA Palo Alto Health Care System
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Comparison of Compensatory Reserve Index to Intravascular Volume Change and Stroke Volume
Comparison of Compensatory Reserve Index to Intravascular Volume Change and Stroke Volume
Status: Enrolling
Updated:  8/30/2013
US Army Institute of Surgical Research
mi
from
San Antonio, TX
Comparison of Compensatory Reserve Index to Intravascular Volume Change and Stroke Volume
Comparison of Compensatory Reserve Index to Intravascular Volume Change and Stroke Volume
Status: Enrolling
Updated: 8/30/2013
US Army Institute of Surgical Research
mi
from
San Antonio, TX
Click here to add this to my saved trials
Parkinsonism in Spinocerebellar Ataxia Type 6
Characterization of the Parkinsonism and Other Non-ataxia Spectrum and Striatal Dopaminergic Degeneration in Spinocerebellar Ataxia Type 6
Status: Enrolling
Updated:  9/4/2013
University of Chicago
mi
from
Chicago, IL
Parkinsonism in Spinocerebellar Ataxia Type 6
Characterization of the Parkinsonism and Other Non-ataxia Spectrum and Striatal Dopaminergic Degeneration in Spinocerebellar Ataxia Type 6
Status: Enrolling
Updated: 9/4/2013
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Pilot Clinical Trial of ACTHar Gel 14 Days Subcutaneous (SQ)Versus ACTHar Gel Five Days SQ for the Treatment of MS Exacerbations
Pilot Clinical Trial of ACTHar Gel 14 Days Subcutaneous (SQ) Versus ACTHar Gel Five Days SQ for the Treatment of MS Exacerbations
Status: Enrolling
Updated:  9/5/2013
The MS Center at the Neurology Center in Southern California
mi
from
Oceanside, CA
Pilot Clinical Trial of ACTHar Gel 14 Days Subcutaneous (SQ)Versus ACTHar Gel Five Days SQ for the Treatment of MS Exacerbations
Pilot Clinical Trial of ACTHar Gel 14 Days Subcutaneous (SQ) Versus ACTHar Gel Five Days SQ for the Treatment of MS Exacerbations
Status: Enrolling
Updated: 9/5/2013
The MS Center at the Neurology Center in Southern California
mi
from
Oceanside, CA
Click here to add this to my saved trials
Pilot Clinical Trial of ACTHar Gel 14 Days Subcutaneous (SQ)Versus ACTHar Gel Five Days SQ for the Treatment of MS Exacerbations
Pilot Clinical Trial of ACTHar Gel 14 Days Subcutaneous (SQ) Versus ACTHar Gel Five Days SQ for the Treatment of MS Exacerbations
Status: Enrolling
Updated:  9/5/2013
The University of Texas-Houston Neurology Clinic
mi
from
Houston, TX
Pilot Clinical Trial of ACTHar Gel 14 Days Subcutaneous (SQ)Versus ACTHar Gel Five Days SQ for the Treatment of MS Exacerbations
Pilot Clinical Trial of ACTHar Gel 14 Days Subcutaneous (SQ) Versus ACTHar Gel Five Days SQ for the Treatment of MS Exacerbations
Status: Enrolling
Updated: 9/5/2013
The University of Texas-Houston Neurology Clinic
mi
from
Houston, TX
Click here to add this to my saved trials
Efficacy and Safety of AIN457 (Secukinumab) in Patients With Relapsing Multiple Sclerosis
A Phase II, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Adaptive Dose-ranging Study to Evaluate the Efficacy and Safety of AIN457 (Secukinumab) in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  9/11/2013
Novartis Investigative Site
mi
from
Cullman, AL
Efficacy and Safety of AIN457 (Secukinumab) in Patients With Relapsing Multiple Sclerosis
A Phase II, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Adaptive Dose-ranging Study to Evaluate the Efficacy and Safety of AIN457 (Secukinumab) in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 9/11/2013
Novartis Investigative Site
mi
from
Cullman, AL
Click here to add this to my saved trials
Efficacy and Safety of AIN457 (Secukinumab) in Patients With Relapsing Multiple Sclerosis
A Phase II, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Adaptive Dose-ranging Study to Evaluate the Efficacy and Safety of AIN457 (Secukinumab) in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  9/11/2013
Novartis Investigative Site
mi
from
Phoenix, AZ
Efficacy and Safety of AIN457 (Secukinumab) in Patients With Relapsing Multiple Sclerosis
A Phase II, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Adaptive Dose-ranging Study to Evaluate the Efficacy and Safety of AIN457 (Secukinumab) in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 9/11/2013
Novartis Investigative Site
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Efficacy and Safety of AIN457 (Secukinumab) in Patients With Relapsing Multiple Sclerosis
A Phase II, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Adaptive Dose-ranging Study to Evaluate the Efficacy and Safety of AIN457 (Secukinumab) in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  9/11/2013
Novartis Investigative Site
mi
from
Sacramento, CA
Efficacy and Safety of AIN457 (Secukinumab) in Patients With Relapsing Multiple Sclerosis
A Phase II, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Adaptive Dose-ranging Study to Evaluate the Efficacy and Safety of AIN457 (Secukinumab) in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 9/11/2013
Novartis Investigative Site
mi
from
Sacramento, CA
Click here to add this to my saved trials
Efficacy and Safety of AIN457 (Secukinumab) in Patients With Relapsing Multiple Sclerosis
A Phase II, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Adaptive Dose-ranging Study to Evaluate the Efficacy and Safety of AIN457 (Secukinumab) in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  9/11/2013
Novartis Investigative Site
mi
from
Stanford, CA
Efficacy and Safety of AIN457 (Secukinumab) in Patients With Relapsing Multiple Sclerosis
A Phase II, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Adaptive Dose-ranging Study to Evaluate the Efficacy and Safety of AIN457 (Secukinumab) in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 9/11/2013
Novartis Investigative Site
mi
from
Stanford, CA
Click here to add this to my saved trials
Efficacy and Safety of AIN457 (Secukinumab) in Patients With Relapsing Multiple Sclerosis
A Phase II, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Adaptive Dose-ranging Study to Evaluate the Efficacy and Safety of AIN457 (Secukinumab) in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  9/11/2013
Novartis Investigative Site
mi
from
Fairfield, CT
Efficacy and Safety of AIN457 (Secukinumab) in Patients With Relapsing Multiple Sclerosis
A Phase II, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Adaptive Dose-ranging Study to Evaluate the Efficacy and Safety of AIN457 (Secukinumab) in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 9/11/2013
Novartis Investigative Site
mi
from
Fairfield, CT
Click here to add this to my saved trials
Efficacy and Safety of AIN457 (Secukinumab) in Patients With Relapsing Multiple Sclerosis
A Phase II, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Adaptive Dose-ranging Study to Evaluate the Efficacy and Safety of AIN457 (Secukinumab) in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  9/11/2013
Novartis Investigative Site
mi
from
North Haven, CT
Efficacy and Safety of AIN457 (Secukinumab) in Patients With Relapsing Multiple Sclerosis
A Phase II, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Adaptive Dose-ranging Study to Evaluate the Efficacy and Safety of AIN457 (Secukinumab) in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 9/11/2013
Novartis Investigative Site
mi
from
North Haven, CT
Click here to add this to my saved trials